Name: Inosine
SKU: 58-63-9

Products Categories

Pharmaceutical (253)
Others (37)
Organic Chemicals (28)
Plant Extract (18)
Reagent (12)
Materials (10)
Food Additives (2)
(1)
Synthetic Flavours & Fragrances (1)

Basic Information

Molecular Structure:
CAS No.:	58-63-9
Name:	Inosine

Formula:	C₁₀H₁₂N₄O₅
Molecular Weight:	268.229
Synonyms:	9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one;4-acetamidobenzoic acid; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione; 9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; 1-dimethylaminopropan-2-ol;6-Hydroxy-9-(β-D-ribofuranosyl)-9H-purine;2',3',5'–Triacetylinosine;iso-prinosine;Inosine (8CI,9CI);hypoxanthine-ribose;.beta.-Inosine;Inosina [INN-Spanish];9-.beta.-D-Ribofuranosylhypoxanthine;Hypoxanthine 9-beta-D-ribofuranoside;Oxiamin;556-08-1;Hypoxanthine, 9-beta-D-ribofuranosyl-;Inosine-Pranobex;Ribonosine;(-)-Inosine;Inotin (TN);Hypoxanthine ribonucleoside;9H-purin-6-ol, 9-pentofuranosyl-;9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one;Inosine [INN:JAN];Atorel;9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one;Inosine (JAN);1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one;beta-D-Ribofuranoside, hypoxanthine-9;
EINECS:	200-390-4
Density:	2.085 g/cm³
Melting Point:	222-226 °C (dec.)(lit.)
Boiling Point:	732.815 °C at 760 mmHg
Flash Point:	396.993 °C
Solubility:	2.1 g/100 mL (20 °C) in water
Appearance:	White crystalline powder
Hazard Symbols:	Xi
Risk Codes:	36/37/38
Safety:	24/25-36-26
PSA:	133.49000
LogP:	-2.26890

Synthetic route

: Acetic acid (2R,3R,4R,5R)-4-acetoxy-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(6-hydroxy-purin-9-yl)-tetrahydro-furan-3-yl ester

A: 58-63-9
inosine

B: 58-61-7
adenosine

Conditions

Conditions	Yield
Multistep reaction;

: 58-61-7
adenosine

: 58-63-9
inosine

Conditions

Conditions	Yield
With sodium phosphate buffer; adenosine deaminase In water at 27℃; pH=7.5; Enzyme kinetics;
With adenosine deaminase Kinetics; Concentration; Enzymatic reaction;
Multi-step reaction with 2 steps 1: purine nucleoside phosphorylase from aeromonas hydrophila II / aq. phosphate buffer / 20 °C / pH 7.5 / Enzymatic reaction 2: aq. phosphate buffer / 20 °C / pH 7.5 View Scheme
With adenine deaminase from E. coli; water In aq. phosphate buffer at 25℃; pH=7.0; Catalytic behavior; Reagent/catalyst; Enzymatic reaction;

: 131-99-7, 21138-48-7, 21214-07-3, 54656-49-4, 56553-00-5
inosine-5'-monophosphate

: 58-63-9
inosine

Conditions

Conditions	Yield
With recombinant nucleoside acid phosphatase/phosphotransferase from Escherichia blattae at 30℃; for 0.166667h; pH=5; Kinetics; Time; pH-value; Temperature; Reagent/catalyst; aq. acetate buffer;

: 58-96-8
uridine

: 58-63-9
inosine

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1.1: potassium phosphate; recombinant Escherichia coli uridine phosphorylase / water / 72 h / 50 °C / pH 7 / Enzymatic reaction 1.2: 24 h / 4 °C 2.1: recombinant Escherichia coli purine nucleoside phosphorylase / 20 °C / pH 7 / Enzymatic reaction View Scheme

: 118-00-3
G

: 58-63-9
inosine

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: purine nucleoside phosphorylase from aeromonas hydrophila II / aq. phosphate buffer / 20 °C / pH 7.5 / Enzymatic reaction 2: aq. phosphate buffer / 20 °C / pH 7.5 View Scheme

: 99790-49-5
α-D-ribose-1-phosphate

: 58-63-9
inosine

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1: aq. phosphate buffer / 20 °C / pH 7.5 2: purine nucleoside phosphorylase from aeromonas hydrophila II / aq. phosphate buffer / 20 °C / pH 7.5 / Enzymatic reaction 3: aq. phosphate buffer / 20 °C / pH 7.5 View Scheme
Multi-step reaction with 3 steps 1: aq. phosphate buffer / 20 °C / pH 7.5 2: purine nucleoside phosphorylase from aeromonas hydrophila II / aq. phosphate buffer / 20 °C / pH 7.5 / Enzymatic reaction 3: aq. phosphate buffer / 20 °C / pH 7.5 View Scheme

: 146469-96-7, 98325-49-6, 98325-50-9
hypoxanthine

: 99790-49-5
α-D-ribose-1-phosphate

: 58-63-9
inosine

Conditions

Conditions	Yield
In aq. phosphate buffer at 20℃; pH=7.5;

: α-D-ribofuranose-1-O-phosphate barium salt

: 68-94-0
6-hydroxypurine

: 58-63-9
inosine

Conditions

Conditions	Yield
With recombinant Escherichia coli purine nucleoside phosphorylase at 20℃; pH=7; Kinetics; Reagent/catalyst; Enzymatic reaction;

: 68-94-0
6-hydroxypurine

: 58-96-8
uridine

: 58-63-9
inosine

Conditions

Conditions	Yield
With recombinant Escherichia coli purine nucleoside phosphorylase; recombinant Escherichia coli uridine phosphorylase at 20℃; pH=7; Enzymatic reaction;

: 68-94-0
Allopurinol

: 58-96-8
uridine

: 58-63-9
inosine

Conditions

Conditions	Yield
With Clostridium perfringens uridine phosphorylase; Aeromonas hydrophila purine nucleosidephosphorylase co-immobilized on glyoxyl-agarose In aq. phosphate buffer at 28℃; under 1034.32 Torr; pH=7.5; Flow reactor; Green chemistry; Enzymatic reaction;

Raw Materials

143-33-9

58-96-8

13035-61-5

65-46-3

68-94-0

3181-38-2

2140-11-6

146-80-5

Downstream Products

58-96-8

68-94-0

Total:242 Page 1 of 7 1 2 3 4 5 6 …7 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 58-63-9

Consensus Reports

Reported in EPA TSCA Inventory.

Specification

The Inosine, with the CAS registry number 58-63-9 and EINECS registry number 200-390-4, has the IUPAC name of 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one. It is a kind of white crystalline powder, and belongs to the following product categories: Nucleotides and Nucleosides; Antivirals for Research and Experimental Use; Biochemistry; Nucleosides, Nucleotides & Related Reagents; Nucleic acids; Bases & Related Reagents. And the molecular formula of the chemical is C₁₀H₁₂N₄O₅.

The Inosine can be found in tRNAs and is essential for proper translation of the genetic code in wobble base pairs. It is an intermediate in a chain of purine nucleotides reactions required for muscle movements. And it has neuroprotective properties. Besides, it is classified as an antiviral in the Anatomical Therapeutic Chemical Classification System. What's more, it can be produced by Straight-Dough Method.

The physical properties of Inosine are as followings: (1)# of Rule of 5 Violations: 0; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 2.004; (5)ACD/KOC (pH 7.4): 2.02; (6)#H bond acceptors: 9; (7)#H bond donors: 4; (8)#Freely Rotating Bonds: 5; (9)Polar Surface Area: 129.2 Å²; (10)Index of Refraction: 1.879; (11)Molar Refractivity: 58.896 cm³; (12)Molar Volume: 128.666 cm³; (13)Polarizability: 23.348×10^-24cm³; (14)Surface Tension: 104.426 dyne/cm; (15)Density: 2.085 g/cm³; (16)Flash Point: 396.993 °C; (17)Enthalpy of Vaporization: 112.251 kJ/mol; (18)Boiling Point: 732.815 °C at 760 mmHg; (19)Vapour Pressure: 0 mmHg at 25°C.

You should be cautious while dealing with this chemical. It irritates to eyes, respiratory system and skin. Therefore, you had better take the following instructions: Avoid contact with skin and eyes. Wear suitable protective clothing, and if in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES: c1[nH]c2c(c(=O)n1)ncn2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
(2)InChI: InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1
(3)InChIKey: UGQMRVRMYYASKQ-KQYNXXCUBA

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Source
mouse	LD50	intraperitoneal	3175mg/kg (3175mg/kg)	Pharmaceutical Chemistry Journal Vol. 20, Pg. 160, 1986.
mouse	LD50	intravenous	> 2800mg/kg (2800mg/kg)	Drugs in Japan Vol. -, Pg. 156, 1995.
mouse	LD50	oral	> 20gm/kg (20000mg/kg)	Drugs in Japan Vol. 6, Pg. 77, 1982.
mouse	LD50	subcutaneous	5gm/kg (5000mg/kg)	Drugs in Japan Vol. 6, Pg. 77, 1982.
rat	LD50	intraperitoneal	2900mg/kg (2900mg/kg)	Drugs in Japan Vol. 6, Pg. 77, 1982.
rat	LD50	intravenous	> 2gm/kg (2000mg/kg)	Drugs in Japan Vol. 6, Pg. 77, 1982.
rat	LD50	oral	> 10gm/kg (10000mg/kg)	Drugs in Japan Vol. -, Pg. 156, 1995.

58-63-9

Refine

Country

Business Type

Certificate

Display

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

58-63-9

Consensus Reports

Specification